Aptose Corporate Presentation July 2024
-2h
Disclosure pursuant to SEBI (Share Based Employee Benefits and Sweat Equity Regulation), 2021
-2h 57m
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
-3h 4m
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
-3h 15m
Details of capital assets created or acquired through CSR spent in FY 2023-24
-3h 17m
CSR Executive Summary - Impact Assessment Report
-3h 17m
CSR detailed Impact Assessment Report
-3h 18m
United States Pharmacopeial Convention Inc.
Expert Committee approves endotoxin testing using non-animal derived reagents
-3h 25m
Notice of 88th Annual General Meeting
-3h 39m
Enabling better clinical outcomes through predictive selection of optimal therapy for each patient
-3h 44m